Autologous peripheral blood stem cell transplantation for Philadelphia chromosome‐positive acute lymphoblastic leukemia is safe but poses challenges for long‐term maintenance of molecular remission: Results of the Auto‐Ph17 study

Autologous hematopoietic stem cell transplantation (SCT) is not a standard treatment option for Philadelphia chromosome‐positive acute lymphoblastic leukemia (Ph+ALL); however, its position has been reassessed since the introduction of tyrosine kinase inhibitors (TKIs). We prospectively analyzed the...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishiwaki, Satoshi, Sugiura, Isamu, Sato, Takahiko, Kobayashi, Miki, Osaki, Masahide, Sawa, Masashi, Adachi, Yoshitaka, Okabe, Motohito, Saito, Shigeki, Morishita, Takanobu, Kohno, Akio, Nishiyama, Takahiro, Iida, Hiroatsu, Kurahashi, Shingo, Kuwatsuka, Yachiyo, Sugiyama, Daisuke, Ito, Sachiko, Nishikawa, Hiroyoshi, Kiyoi, Hitoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Haematologic Malignancy ‐ Lymphoid
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10188459/
https://www.ncbi.nlm.nih.gov/pubmed/37206256
http://dx.doi.org/10.1002/jha2.677

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10188459/
https://www.ncbi.nlm.nih.gov/pubmed/37206256
http://dx.doi.org/10.1002/jha2.677

Ejemplares similares